Omega 3: a novel treatment agent in oral submucous fibrosis: a pilot study-Reference-Cited by-同舟云学术

Omega 3: a novel treatment agent in oral submucous fibrosis: a pilot study

Author:

Raizada Milanjeet Kaur¹,Sable Digamber M²,Chowdhery Asha³,Chavan Mahesh Shivaji⁴,Rajpurohit Ladu Singh⁵

Affiliation:

1. Oral Medicine & Radiology; Panineeya Mahavidyalaya Institute of Dental Sciences and Research Centre; Hyderabad Telangana India

2. Oral Medicine & Radiology; Dr. D. Y. Patil Dental College & Hospital; DPU; Pune Maharashtra India

3. Department of Oral and Medicine & Radiology; Dr. D. Y. Patil Dental College and Hospital; Pune Maharashtra India

4. Oral Medicine and Radiology; Dr. D. Y. Patil Dental College; Pune Maharashtra India

5. Department of Public health dentistry; Dr. D.Y.Patil Dental College & Hospital; DPU; Pune Maharashtra India

Publisher

Wiley

Subject

Periodontics,Cancer Research,Otorhinolaryngology,Oral Surgery,Pathology and Forensic Medicine

Link

Reference22 articles.

3. lycopene in the management of oral submucous fibrosis;Selvam;Asian J Pharm Clin Res,2013

4. Drug treatment of oral sub mucous fibrosis - A Review;Chole;Int J Contemp Med Res,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interventions for managing oral submucous fibrosis;Cochrane Database of Systematic Reviews;2024-02-28